Deletion of tumor necrosis factor-α ameliorates neurodegeneration in sandhoff disease mice

Human Molecular Genetics

Volumn 22, Issue 19, 2013, Pages 3960-3975

  Abo ouf, Hatem ^a   Hooper, Alexander W M ^a   White, Elizabeth J ^a   Van Rensburg, Helena J Janse ^a   Trigatti, Bernardo L ^a   Igdoura, Suleiman A ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GANGLIOSIDE; JANUS KINASE 2; STAT3 PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; ASTROCYTE; ASTROCYTOSIS; BONE MARROW TRANSPLANTATION; CELL ACTIVATION; CONTROLLED STUDY; COORDINATION; DISEASE COURSE; MICROGLIA; MOUSE; NERVE CELL; NERVE DEGENERATION; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; SANDHOFF DISEASE;

ANIMALS; BETA-N-ACETYLHEXOSAMINIDASES; BONE MARROW TRANSPLANTATION; BRAIN; CELL DEATH; DISEASE MODELS, ANIMAL; FEMALE; GANGLIOSIDES; GLIOSIS; HUMANS; MICE; MICE, KNOCKOUT; MICROGLIA; SANDHOFF DISEASE; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84884240246     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddt250     Document Type: Article

References (55)

1. Hodges, B.L. and Cheng, S.H. (2006) Cell and gene-based therapies for the lysosomal storage diseases. Curr. Gene Ther., 6, 227-241.
2. Kolter, T. and Sandhoff, K. (2006) Sphingolipid metabolism diseases. Biochim. Biophys. Acta, 1758, 2057-2079.
3. Meier, E.M., Schwarzmann, G., Furst, W. and Sandhoff, K. (1991) The human GM2 activator protein. A substrate specific cofactor of beta-hexosaminidase a. J. Biol. Chem., 266, 1879-1887.
4. Conzelmann, E., Kytzia, H.J., Navon, R. and Sandhoff, K. (1983) Ganglioside GM2 N-acetyl-beta-D-galactosaminidase activity in cultured fibroblasts of late-infantile and adult GM2 gangliosidosis patients and of healthy probands with low hexosaminidase level. Am. J. Hum. Genet., 35, 900-913.
5. Sango, K., Yamanaka, S., Hoffmann, A., Okuda, Y., Grinberg, A., Westphal, H.,Mcdonald, M.P., Crawley, J.N., Sandhoff, K., Suzuki, K. and Proia, R.L. (1995) Mousemodels ofTay-Sachs andSandhoff diseases differ in neurologic phenotype and ganglioside metabolism. Nat. Genet., 11, 170-176.
6. Yamanaka, S., Johnson, M.D., Grinberg, A., Westphal, H., Crawley, J.N., Taniike, M., Suzuki, K. and Proia, R.L. (1994) Targeted disruption of the hexa gene results in mice with biochemical and pathologic features of Tay-Sachs disease. Proc. Natl Acad. Sci. USA, 91, 9975-9979.
7. Miklyaeva, E.I., Dong, W., Bureau, A., Fattahie, R., Xu, Y., Su, M., Fick, G.H., Huang, J.Q., Igdoura, S., Hanai, N. and Gravel, R.A. (2004) Late onset Tay-Sachs disease in mice with targeted disruption of the hexa gene: behavioral changes and pathology of the central nervous system. Brain Res., 1001, 37-50.
8. Wu, Y.P. and Proia, R.L. (2004) Deletion of macrophage-inflammatory protein 1 alpha retards neurodegeneration in Sandhoff disease mice. Proc. Natl Acad. Sci. USA, 101, 8425-8430.
9. Kyrkanides, S., Miller, A.W., Miller, J.N., Tallents, R.H., Brouxhon, S.M., Olschowka, M.E., O'banion, M.K. and Olschowka, J.A. (2008) Peripheral blood mononuclear cell infiltration and neuroinflammation in the hexb-/- mouse model of neurodegeneration. J. Neuroimmunol., 203, 50-57.
10. Niederkorn, J.Y. (2006) See no evil, hear no evil, do no evil: the lessons of immune privilege. Nat. Immunol., 7, 354-359.
11. Probert, L., Akassoglou, K., Kassiotis, G., Pasparakis, M., Alexopoulou, L. and Kollias, G. (1997) TNF-Alpha transgenic and knockout models of CNS inflammation and degeneration. J. Neuroimmunol., 72, 137-141.
12. Mrak, R.E. and Griffin, W.S. (2005) Glia and their cytokines in progression of neurodegeneration. Neurobiol. Aging, 26, 349-354.
13. Mcgeer, P.L. and Mcgeer, E.G. (2001) Inflammation, autotoxicity and Alzheimer's disease. Neurobiol. Aging, 22, 799-809.
14. Mcgeer, P.L. and Mcgeer, E.G. (2004) Inflammation and neurodegeneration in Parkinson's disease. Parkinsonism. Relat. Disord., 10(Suppl. 1), S3-S7.
15. Shie, F.S. and Woltjer, R.L. (2007) Manipulation of microglial activation as a therapeutic strategy in Alzheimer's disease. Curr. Med. Chem., 14, 2865-2871.
16. Huang, J.Q., Trasler, J.M., Igdoura, S., Michaud, J., Hanal, N. and Gravel, R.A. (1997) Apoptotic cell death in mouse models of GM2 gangliosidosis and observations on human Tay-Sachs and Sandhoff diseases. Hum. Mol. Genet., 6, 1879-1885.
17. Wu, Y.P., Mizugishi, K., Bektas, M., Sandhoff, R. and Proia, R.L. (2008) Sphingosine kinase 1/S1P receptor signaling axis controls glial proliferation in mice with Sandhoff disease. Hum. Mol. Genet., 17, 2257-2264.
18. Myerowitz, R., Lawson, D., Mizukami, H., Mi, Y., Tifft, C.J. and Proia, R.L. (2002) Molecular pathophysiology in Tay-Sachs and Sandhoff diseases as revealed by gene expression profiling. Hum. Mol. Genet., 11, 1343-1350.
19. Jeyakumar, M., Thomas, R., Elliot-Smith, E., Smith, D.A., Van Der Spoel, A.C., D'azzo, A., Perry, V.H., Butters, T.D., Dwek, R.A. and Platt, F.M. (2003) Central nervous system inflammation is a hallmark of pathogenesis in mouse models of GM1 and GM2 gangliosidosis. Brain, 126, 974-987.
20. Shishodia, S. and Aggarwal, B.B. (2002) Nuclear Factor-kappaB activation: a question of life or death. J. Biochem. Mol. Biol., 35, 28-40.
21. Ting, A.Y. and Endy, D. (2002) Signal transduction. Decoding NF-kappaB signaling. Science, 298, 1189-1190.
22. Lee, J.P., Jeyakumar, M., Gonzalez, R., Takahashi, H., Lee, P.J., Baek, R.C., Clark, D., Rose, H., Fu, G., Clarke, J. et al. (2007) Stem cells act through multiple mechanisms to benefit mice with neurodegenerative metabolic disease. Nat. Med., 13, 439-447.
23. Sofroniew, M.V. and Vinters, H.V. (2010) Astrocytes: biology and pathology. Acta Neuropathol., 119, 7-35.
24. Kettenmann, H. (2007) Neuroscience: the Brain's garbage men. Nature, 446, 987-989.
25. Hirota, K., Matsui, M., Murata, M., Takashima, Y., Cheng, F.S., Itoh, T., Fukuda, K. and Yodoi, J. (2000) Nucleoredoxin, glutaredoxin, and thioredoxin differentially regulate NF-kappaB, AP-1, and CREB activation in HEK293 cells. Biochem. Biophys. Res. Commun., 274, 177-182.
26. Sun, S.C. (2011) Non-canonical NF-kappaB signaling pathway. Cell Res., 21, 71-85.
27. Wajant, H., Pfizenmaier, K. and Scheurich, P. (2003) Tumor necrosis factor signaling. Cell Death. Differ., 10, 45-65.
28. Fontaine, V., Mohand-Said, S., Hanoteau, N., Fuchs, C., Pfizenmaier, K. and Eisel, U. (2002) Neurodegenerative and neuroprotective effects of tumor necrosis factor (TNF) in retinal ischemia: opposite roles of tnf receptor 1 and tnf receptor 2. J. Neurosci., 22, Rc216.
29. Murakami, Y., Saito, K., Hara, A., Zhu, Y., Sudo, K., Niwa, M., Fujii, H., Wada, H., Ishiguro, H., Mori, H. and Seishima, M. (2005) Increases in tumor necrosis factor-alpha following transient global cerebral ischemia do not contribute to neuron death in mouse hippocampus. J. Neurochem., 93, 1616-1622.
30. Wada, R., Tifft, C.J. and Proia, R.L. (2000) Microglial activation precedes acute neurodegeneration in Sandhoff disease and is suppressed by bone marrow transplantation. Proc. Natl Acad. Sci. USA, 97, 10954-10959.
31. Akiyama, H., Barger, S., Barnum, S., Bradt, B., Bauer, J., Cole, G.M., Cooper, N.R., Eikelenboom, P., Emmerling, M., Fiebich, B.L. et al. (2000) Inflammation and Alzheimer's disease. Neurobiol. Aging, 21, 383-421.
32. Norflus, F., Tifft, C.J., Mcdonald, M.P., Goldstein, G., Crawley, J.N., Hoffmann, A., Sandhoff, K., Suzuki, K. and Proia, R.L. (1998) Bone marrow transplantation prolongs life span and ameliorates neurologic manifestations in Sandhoff disease mice. J. Clin. Invest., 101, 1881-1888.
33. Teng, Y.D., Lavik, E.B., Qu, X., Park, K.I., Ourednik, J., Zurakowski, D., Langer, R. and Snyder, E.Y. (2002) Functional recovery following traumatic spinal cord injury mediated by a unique polymer scaffold seeded with neural stem cells. Proc. Natl Acad. Sci. USA, 99, 3024-3029.
34. Jeyakumar, M., Smith, D.A., Williams, I.M., Borja, M.C., Neville, D.C., Butters, T.D., Dwek, R.A. and Platt, F.M. (2004) NSAIDS increase survival in the Sandhoff disease mouse: synergy with N-butyldeoxynojirimycin. Ann. Neurol., 56, 642-649.
35. Raval, G., Biswas, S., Rayman, P., Biswas, K., Sa, G., Ghosh, S., Thornton, M., Hilston, C., Das, T., Bukowski, R. et al. (2007) TNF-Alpha induction of GM2 expression on renal cell carcinomas promotes t cell dysfunction. J. Immunol., 178, 6642-6652.
36. Igdoura, S.A., Mertineit, C., Trasler, J.M. and Gravel, R.A. (1999) Sialidase-mediated depletion of GM2 ganglioside in Tay-Sachs neuroglia Cells. Hum. Mol. Genet., 8, 1111-1116.
37. Jeyakumar, M., Dwek, R.A., Butters, T.D. and Platt, F.M. (2005) Storage solutions: treating lysosomal disorders of the brain. Nat. Rev. Neurosci., 6, 713-725.
38. Culmsee, C. and Plesnila, N. (2006) Targeting bid to prevent programmed cell death in neurons. Biochem. Soc. Trans., 34, 1334-1340.
39. Zhang, L., Zhao, W., Li, B., Alkon, D.L., Barker, J.L., Chang, Y.H., Wu, M. and Rubinow, D.R. (2000) TNF-Alpha induced over-expression of GFAP is associated with MAPKs. Neuroreport, 11, 409-412.
40. Tsuda, M., Kohro, Y., Yano, T., Tsujikawa, T., Kitano, J., Tozaki-Saitoh, H., Koyanagi, S., Ohdo, S., Ji, R.R., Salter, M.W. and Inoue, K. (2011) JAK-STAT3 pathway regulates spinal astrocyte proliferation and neuropathic pain maintenance in rats. Brain, 134, 1127-1139.
41. Sakuraba, H., Sawada, M., Matsuzawa, F., Aikawa, S., Chiba, Y., Jigami, Y. and Itoh, K. (2006) Molecular pathologies of an enzyme replacement therapies for lysosomal diseases. CNS Neurol. Disord. Drug Targets, 5, 401-413.
42. Futerman, A.H. and Van, M.G. (2004) The cell biology of lysosomal storage disorders. Nat. Rev. Mol. Cell Biol., 5, 554-565.
43. Nilsson, C.L., Dillon, R., Devakumar, A., Shi, S.D., Greig, M., Rogers, J.C., Krastins, B., Rosenblatt, M., Kilmer, G., Major,M. et al. (2010) Quantitative phosphoproteomic analysis of the STAT3/IL-6/HIF1alpha signaling network: an initial study in GSC11 glioblastoma stem cells. J. Proteome Res., 9, 430-443.
44. Walkley, S.U. (2009) Pathogenic cascades in lysosomal disease-why so complex? J. Inherit. Metab. Dis., 32, 181-189.
45. Suzuki, S., Yamashita, T., Tanaka, K., Hattori, H., Sawamoto, K., Okano, H. and Suzuki, N. (2005) Activation of cytokine signaling through leukemia inhibitory factor receptor (LIFR)/gp130 attenuates ischemic brain injury in rats. J. Cereb. Blood Flow Metab., 25, 685-693.
46. Park, K.W., Nozell, S.E. and Benveniste, E.N. (2012) Protective role of STAT3 in nmda and glutamate-induced neuronal death: negative regulatory effect of SOCS3. PLoS One, 7, E50874.
47. Guo, D., Dunbar, J.D., Yang, C.H., Pfeffer, L.M. and Donner, D.B. (1998) Induction of jak/stat signaling by activation of the type 1 TNF receptor. J. Immunol., 160, 2742-2750.
48. Pincheira, R., Castro, A.F., Ozes, O.N., Idumalla, P.S. and Donner, D.B. (2008) Type 1 TNF receptor forms a complex with and uses JAK2 and C-SRC to selectively engage signaling pathways that regulate transcription factor activity. J. Immunol., 181, 1288-1298.
49. Hebert, S.S. and De, S.B. (2009) Alterations of the microrna network cause neurodegenerative disease. Trends Neurosci., 32, 199-206.
50. Vallabhapurapu, S., Matsuzawa, A., Zhang, W., Tseng, P.H., Keats, J.J., Wang, H., Vignali, D.A., Bergsagel, P.L. and Karin, M. (2008) Nonredundant and complementary functions of TRAF2 and TRAF3 in a ubiquitination cascade that activates NIK-dependent alternative NF-kappaB signaling. Nat. Immunol., 9, 1364-1370.
51. Rauert, H., Wicovsky, A., Muller, N., Siegmund, D., Spindler, V., Waschke, J., Kneitz, C. and Wajant, H. (2010) Membrane tumor necrosis factor (tnf) induces p100 processing via TNF receptor-2 (TNFR2). J. Biol. Chem., 285, 7394-7404.
52. Jeyakumar, M., Norflus, F., Tifft, C.J., Cortina-Borja, M., Butters, T.D., Proia, R.L., Perry, V.H., Dwek, R.A. and Platt, F.M. (2001) Enhanced survival in Sandhoff disease mice receiving a combination of substrate deprivation therapy and bone marrow transplantation. Blood, 97, 327-329.
53. Irwin, S. (1968) Comprehensive observational assessment: ia.Asystematic, quantitative procedure for assessing the behavioral and physiologic state of the mouse. Psychopharmacologia, 13, 222-257.
54. Mcdaniel, K.L. and Moser, V.C. (1993) Utility of a neurobehavioral screening battery for differentiating the effects of two pyrethroids, permethrin and cypermethrin. Neurotoxicol. Teratol., 15, 71-83.
55. Irwin, C.C. and Irwin, L.N. (1979) A simple rapid method for ganglioside isolation from small amounts of tissue. Anal. Biochem., 94, 335-339.